Affordable Access

Publisher Website

Isobutylmethylxanthine enhances adrenergic-induced ocular hypotension in rabbits and beagles

Authors
Journal
Experimental Eye Research
0014-4835
Publisher
Elsevier
Publication Date
Volume
52
Issue
5
Identifiers
DOI: 10.1016/0014-4835(91)90051-f
Keywords
  • Intraocular Pressure
  • Isobutylmethylxanthine
  • Catecholamines
  • Aqueous Humour Protein
  • Aqueous Humour Cyclic-Amp
  • Rabbit
  • Dog

Abstract

Abstract Isobutylmethylxanthine (IBMX), a phosphodiesterase/adenosine receptor inhibitor, was combined with norepinephrine (nE), epinephrine (Epi) and isoproterenol, respectively, to evaluate their effect on intraocular pressure (IOP). Application of topical IBMX alone had no measurable effect on IOP. When IBMX was combined with nE or Epi the ocular hypotension in rabbits and beagles increased. The E max for nE alone was 2·9±0·4 mmHg, for Epi alone 7·3±0·5 mmHg and for isoproterenol alone 5·1±0·3 mmHg. The EC 50 was 0·2±0·05% (nE), 0·05±0·01% (Epi) and 0·00±0·001% for isoproterenol. When given in combination with 1% IBMX the E max for nE was 7·4±1·7 mmHg, for Epi 9·0±0·8 mmHg and for isoproterenol 6·1±0·3 mmHg. The corresponding values for EC 50 were 0·07±0·03% (nE), 0·02±0.006% (Epi) and 0·002±0·001% for isoproterenol. Combining 1% IBMX with 0·1% Epi increased the aqueous humour cyclic AMP-levels at 1, 3 and 5 hr in rabbits. The results of this study demonstrate that a phosphodiesterase/adenosine receptor inhibitor such as IBMX enhances the reduction in IOP induced by adrenergic agonists.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Isobutylmethylxanthine enhances adrenergic-induced...

on Experimental Eye Research May 1991

Soluble forms of isobutylmethylxanthine enhance th...

on Graefe's archive for clinical... 1991

Fadolmidine-induced ocular hypotension in normoten...

on The Journal of pharmacy and ph... February 2005

Dexmedetomidine-induced ocular hypotension in rabb...

on Investigative Ophthalmology &... May 1992
More articles like this..